Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data.

Autor: Kim SY; Veracyte, South San Francisco, CA, USA., Diggans J; Veracyte, South San Francisco, CA, USA., Pankratz D; Veracyte, South San Francisco, CA, USA., Huang J; Veracyte, South San Francisco, CA, USA., Pagan M; Veracyte, South San Francisco, CA, USA., Sindy N; Veracyte, South San Francisco, CA, USA., Tom E; Veracyte, South San Francisco, CA, USA., Anderson J; Veracyte, South San Francisco, CA, USA., Choi Y; Veracyte, South San Francisco, CA, USA., Lynch DA; National Jewish Health, Denver, CO, USA., Steele MP; Vanderbilt University, Nashville, TN, USA., Flaherty KR; University of Michigan, Ann Arbor, MI, USA., Brown KK; National Jewish Health, Denver, CO, USA., Farah H; Hannibal Clinic, Hannibal, MO, USA., Bukstein MJ; Hannibal Clinic, Hannibal, MO, USA., Pardo A; Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico., Selman M; Instituto Nacional de Enfermedades Respiratorias, DF, Mexico., Wolters PJ; University of California, San Francisco, CA, USA., Nathan SD; Inova Fairfax Hospital, Falls Church, VA, USA., Colby TV; Mayo Clinic, Scottsdale, AZ, USA., Myers JL; University of Michigan, Ann Arbor, MI, USA., Katzenstein AL; SUNY Upstate Medical University, Syracuse, NY, USA., Raghu G; University of Washington Medical Center, Seattle, WA, USA., Kennedy GC; Veracyte, South San Francisco, CA, USA. Electronic address: giulia@veracyte.com.

Publikováno v: The Lancet. Respiratory medicine [Lancet Respir Med] 2015 Jun; Vol. 3 (6), pp. 473-82. Date of Electronic Publication: 2015 May 20.

Molecular approach to the classification of chronic fibrosing lung disease—there and back again.

Autor: Verleden, Stijn E., Braubach, Peter, Kuehnel, Mark, Dickgreber, Nicolas, Brouwer, Emily, Tittmann, Pauline, Laenger, Florian, Jonigk, Danny

Publikováno v: Virchows Archiv: European Journal of Pathology; Jan2021, Vol. 478 Issue 1, p89-99, 11p

Molecular approach to the classification of chronic fibrosing lung disease-there and back again.

Autor: Verleden SE; Institute of Pathology, Hannover Medical School, Hannover, Germany. Stijn.verleden@kuleuven.be.; BREATHE Lab, Department of CHROMETA, KU Leuven, Leuven, Belgium. Stijn.verleden@kuleuven.be., Braubach P; Institute of Pathology, Hannover Medical School, Hannover, Germany.; Member of the German Center for Lung Research, Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH), Hannover, Germany., Kuehnel M; Institute of Pathology, Hannover Medical School, Hannover, Germany.; Member of the German Center for Lung Research, Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH), Hannover, Germany., Dickgreber N; Department of Respiratory Medicine and Thoracic Oncology, Ibbenbueren General Hospital, Ibbenbueren, Germany., Brouwer E; Institute of Pathology, Hannover Medical School, Hannover, Germany.; Member of the German Center for Lung Research, Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH), Hannover, Germany., Tittmann P; Institute of Pathology, Hannover Medical School, Hannover, Germany.; Member of the German Center for Lung Research, Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH), Hannover, Germany., Laenger F; Institute of Pathology, Hannover Medical School, Hannover, Germany.; Member of the German Center for Lung Research, Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH), Hannover, Germany., Jonigk D; Institute of Pathology, Hannover Medical School, Hannover, Germany.; Member of the German Center for Lung Research, Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH), Hannover, Germany.

Publikováno v: Virchows Archiv : an international journal of pathology [Virchows Arch] 2021 Jan; Vol. 478 (1), pp. 89-99. Date of Electronic Publication: 2020 Nov 09.